Cardiol Therapeutics
CRDL | NASDAQ
$0.98
-$0.02 (-2.00%)
At close: Nov 16, 2026, 4:00 PM ET
$0.99
+$0.01 (+1.43%)
After-hours:
Nov 16, 2026, 6:56 PM ET
-2.00%
(1D)No price chart data available for 1D timeframe.
Rating
36.2
+1.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #632/1021 (Top 62%)
Key Statistics
Market Data
Market Cap $118.22M
1D Range
0.96 1.01
52W Range
0.93 2.29
Valuation (TTM)
PE -3.88
PB 6.07
EV/EBITDA -3.81
Valuation (NTM)
Forward PE N/A
Forward PEG 0.60
Price Target $8.00
Cash Flow
FCF Yield -12.8%
SBC Adj. FCF Yield -15.7%
SBC Impact -22.4%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-100.0%
Dil EPS 3Y | 5Y 21.4% |
5.8%
FCF 3Y | 5Y 8.9% |
-1.0%
Returns
ROA -113.8%
ROE -159.8%
ROIC -128.1%
Financial Health
Net Cash
C$29.29M ($20.58M)
Current Ratio 6.26
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Cardiol Therapeutics Inc. is a clinical-stage life sciences firm dedicated to discovering and advancing anti-fibrotic and anti-inflammatory therapies for cardiovascular disease (CVD). Its leading cand...
Sector Healthcare
Employees 18
IPO Date Jan 15, 2019
Website www.cardiolrx.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$8.00
Upside
+716.33%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CRDL